Thermo Fisher Scientific Derivative Liability, Subject to Master Netting Arrangement, Asset Offset increased by 39.2% to $444.00M in Q1 2026 compared to the prior quarter. This increase may warrant attention — for this metric, lower values are generally preferred.
A decrease in this value relative to gross liabilities indicates a reduction in net settlement obligations, whereas an increase suggests higher net liability exposure to counterparties.
This metric represents the gross fair value of derivative liabilities that are subject to a master netting arrangement,...
Standardized disclosure across global financial services firms, allowing investors to compare the net liability exposure of derivative portfolios across different insurance and banking peers.
other_derivative_liability_fair_value_gross_asset| Q4 '25 | Q1 '26 | |
|---|---|---|
| Value | $319.00M | $444.00M |
| QoQ Change | — | +39.2% |